Resistance to MAP-kinase Pathway Inhibitors in Metastatic Melanoma. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
To investigate clinical mechanisms of resistance MAP-kinase pathway inhibitors in metastatic melanoma, we performed whole exome sequencing and transcriptome sequencing on pre-treatment, post-resistance, and, in some cases, on-treatment tumor biopsies obtained from patients treated with RAF inhibitors or RAF/MEK inhibitor combinations.
创建时间：
2016-02-09
